GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (360)

Latest Posts

About This Stock More About This Stock
Glaxo (GSK) Beats On Q3 Earnings & Sales, Raises '18 View
Article By: Zacks Investment Research
Friday, November 2, 2018 3:00 PM EST
GlaxoSmithKline plc GSK​ reported core earnings of 93 cents per American depositary share in the third quarter of 2018, which beat the Zacks Consensus Estimate of 86 cents. Earnings were up 14% at constant exchange rate from the year-ago figure.
In this article: GSK Also: LLY, NVS, MYL
Read
E Don't Cry For Me, Argentina
Article By: Vivian Lewis
Sunday, September 9, 2018 10:28 AM EST
Stronger currencies chopped the prices of most foreign stocks last week, a side effect of the move out of emerging markets currencies which is continuing, and out of the dollar, which is strengthening.
In this article: BUD, CZZ, GSK, LLY, NVS, SNY, TEI, VOD, CGRIF, OROCF, RHHBY, TEVA, GLD, ZYME
Read
Week In Review: Jiangsu Hansoh To Raise Up To $3 Billion In Hong Kong IPO
Article By: ChinaBio® Today
Saturday, September 8, 2018 4:22 PM EST
Hansoh, a China pharma based in Lianyungang, Jiangsu province, has applied to stage an IPO on the Hong Kong exchange. Unlike most companies seeking Hong Kong IPOs, Hansoh is both profitable and established.
In this article: GSK, LLY, BGNE, ZLAB, ROG, HCM, MRK
Read
Does A Good Track Record Mean GSK's 5% Yield Is Safe?
Article By: Marc Lichtenfeld
Wednesday, August 22, 2018 10:30 PM EST
Drug giant GlaxoSmithKline seems like it has been in turnaround mode for several years.
In this article: GSK
Read
The Top 11 Big Pharma Dividend Stocks Ranked By Total Return
Article By: SureDividend
Monday, July 16, 2018 8:04 PM EST
Drug companies are often considered defensive in nature due to their stable earnings, through good economies and bad.
In this article: LLY, MRK, AZN, BMY, AMGN, GILD, PFE, ABBV, GSK, NVS, SNY
Read

PARTNER HEADLINES

Latest Tweets for $GSK

No tweets yet!